Published in Radiology on February 01, 2012
MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours. Eur Radiol (2012) 1.47
The role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a review. Radiol Bras (2015) 1.09
ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents. Eur Radiol (2015) 1.03
Hypervascular benign and malignant liver tumors that require differentiation from hepatocellular carcinoma: key points of imaging diagnosis. Liver Cancer (2014) 1.01
Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI. World J Hepatol (2014) 0.96
Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging. Eur Radiol (2015) 0.88
Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media. Quant Imaging Med Surg (2014) 0.88
The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase. Clin Mol Hepatol (2013) 0.88
Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions. BMC Med Imaging (2013) 0.87
"Incidentaloma" of the liver: management of a diagnostic and therapeutic dilemma. HPB Surg (2012) 0.86
Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification. Int J Hepatol (2013) 0.86
Hepatic inflammatory pseudotumor misinterpreted as hepatocellular carcinoma. Clin Mol Hepatol (2012) 0.86
Liver-specific agents for contrast-enhanced MRI: role in oncological imaging. Cancer Imaging (2013) 0.84
Multiparametric MR Imaging in Abdominal Malignancies. Magn Reson Imaging Clin N Am (2016) 0.83
The role of MRI using liver-specific contrast agent in the assessment of focal liver lesion. Radiol Bras (2015) 0.82
Liver masses: a clinical, radiologic, and pathologic perspective. Clin Gastroenterol Hepatol (2013) 0.81
The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis. Eur Radiol (2014) 0.81
The impact of hepatocyte phase imaging from infancy to young adulthood in patients with a known or suspected liver lesion. Pediatr Radiol (2014) 0.80
Focal nodular hyperplasia: a review of current indications for and outcomes of hepatic resection. HPB (Oxford) (2013) 0.80
Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Eur Radiol (2014) 0.80
Imaging of multifocal liver lesions in children and adolescents. Cancer Imaging (2013) 0.79
MR Imaging of Hepatocellular Adenomas and Differential Diagnosis Dilemma. Int J Hepatol (2013) 0.79
Comparison of Dynamic and Liver-Specific Gadoxetic Acid Contrast-Enhanced MRI versus Apparent Diffusion Coefficients. PLoS One (2013) 0.78
The value of liver resection for focal nodular hyperplasia: resection yes or no? Eur J Med Res (2015) 0.78
Characterization of fortuitously discovered focal liver lesions: additional information provided by shearwave elastography. Eur Radiol (2014) 0.78
Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI. Acad Radiol (2014) 0.78
Focal nodular hyperplasia: characterisation at gadoxetic acid-enhanced MRI and diffusion-weighted MRI. Br J Radiol (2013) 0.77
Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI. PLoS One (2014) 0.77
Non-invasive diagnosis of abdomino-pelvic masses: role of multimodality imaging. J Clin Imaging Sci (2013) 0.76
Combined dynamic contrast-enhanced liver MRI and MRA using interleaved variable density sampling. Magn Reson Med (2014) 0.76
Inter-observer agreement on the assessment of relative liver lesion signal intensity on hepatobiliary phase imaging with gadoxetate (Gd-EOB-DTPA). Abdom Radiol (2016) 0.75
Focal liver lesions: Practical magnetic resonance imaging approach. World J Hepatol (2015) 0.75
Safety and Efficacy of Gadoxetate Disodium-Enhanced Liver MRI in Pediatric Patients Aged >2 Months to <18 Years-Results of a Retrospective, Multicenter Study. Magn Reson Insights (2016) 0.75
That liver lesion on MDCT in the oncology patient: is it important? Cancer Imaging (2012) 0.75
Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents? World J Gastroenterol (2016) 0.75
Magnetic Resonanance Imaging of the Liver (Including Biliary Contrast Agents)-Part 2: Protocols for Liver Magnetic Resonanance Imaging and Characterization of Common Focal Liver Lesions. Semin Roentgenol (2016) 0.75
Diffusion weighted MR and apparent diffusion coefficient measurement in classification and characterization of noncystic focal liver lesions: does a clinical role exist? Medicine (Baltimore) (2014) 0.75
Treatment of a non-typical hepatic pseudolesion complicated by greatly elevated alpha fetoprotein: case report and literature review. World J Surg Oncol (2013) 0.75
Hepatic adenomatosis in liver cirrhosis. Eur J Radiol Open (2017) 0.75
A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma. Eur Radiol (2017) 0.75
Benign nodular hyperplasia of the liver-pedunculated form: diagnostic contributions of ultrasonography and consideration of exophytic liver tumors. J Med Ultrason (2001) (2014) 0.75
[Hepatocellular tumours in noncirrhotic liver tissue]. Pathologe (2015) 0.75
Diagnostic Value of Gd-EOB-DTPA-MRI for Hepatocellular Adenoma: A Meta-Analysis. J Cancer (2017) 0.75
Gadoxetic acid disodium-enhanced MR imaging of cholangiolocellular carcinoma of the liver: imaging characteristics and histopathological correlations. Eur Radiol (2017) 0.75
Intravoxel incoherent motion and dynamic contrast-enhanced MRI for differentiation between hepatocellular adenoma and focal nodular hyperplasia. Br J Radiol (2017) 0.75
Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology (2004) 8.36
Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol (2007) 4.73
Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol (2008) 3.50
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology (2007) 3.39
Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies. Hepatology (2002) 2.18
Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J Hepatol (2005) 1.83
Using hierarchical modeling in genetic association studies with multiple markers: application to a case-control study of bladder cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.72
Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol (2004) 1.60
Structural alterations of subcutaneous small-resistance arteries may predict major cardiovascular events in patients with hypertension. Am J Hypertens (2007) 1.59
The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients. Liver Int (2010) 1.51
The pathology of gastric cardia: a prospective, endoscopic, and morphologic study. Am J Surg Pathol (2007) 1.48
Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS (2004) 1.44
Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. Radiology (2011) 1.43
GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer (2004) 1.41
Cancer incidence in people with AIDS in Italy. Int J Cancer (2010) 1.39
Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin Gastroenterol Hepatol (2007) 1.38
Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging (2011) 1.26
HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage. Clin Cancer Res (2005) 1.22
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease. Blood (2010) 1.21
High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma. J Magn Reson Imaging (2009) 1.18
Hypovascular hypointense nodules on hepatocyte phase gadoxetic acid-enhanced MR images: too early or too progressed to determine hypervascularity. Radiology (2013) 1.13
Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomarkers Prev (2003) 1.11
Fine-needle aspiration biopsy of low-grade cribriform cystadenocarcinoma of the salivary gland. Diagn Cytopathol (2011) 1.09
GHPSS multicenter Italian survey: smoking prevalence, knowledge and attitudes, and tobacco cessation training among third-year medical students. Tumori (2013) 1.08
Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magn Reson Med Sci (2012) 1.08
Constipation, anthranoid laxatives, melanosis coli, and colon cancer: a risk assessment using aberrant crypt foci. Cancer Epidemiol Biomarkers Prev (2002) 1.06
A comparison of mean displacement values using high b-value Q-space diffusion-weighted MRI with conventional apparent diffusion coefficients in patients with stroke. Acad Radiol (2011) 1.04
Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging. J Magn Reson Imaging (2011) 1.04
Radiofrequency ablation of hepatocellular carcinoma: long-term experience with expandable needle electrodes. AJR Am J Roentgenol (2006) 1.01
Occupation and larynx and hypopharynx cancer: an international case-control study in France, Italy, Spain, and Switzerland. Cancer Causes Control (2003) 1.01
Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration. Invest Radiol (2011) 0.99
Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease. Liver Int (2007) 0.98
Anomalous pancreaticobiliary junction shown on multidetector CT. AJR Am J Roentgenol (2003) 0.98
Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure. Cardiovasc Drugs Ther (2010) 0.95
Transient hepatic attenuation difference (THAD) in biliary duct disease. Abdom Imaging (2009) 0.95
Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging (2011) 0.94
Comparative assessment of genotoxicity of mineral water packed in polyethylene terephthalate (PET) and glass bottles. Water Res (2009) 0.93
Effectiveness and tolerability of combination treatment of chronic hepatitis C in illicit drug users: meta-analysis of prospective studies. Clin Ther (2010) 0.92
Genetic causes of bronchiectasis: primary immune deficiencies and the lung. Respiration (2007) 0.91
Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era. AIDS Res Hum Retroviruses (2013) 0.91
Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on gadoxetic acid-DTPA (Gd-EOB-DTPA)-enhanced hepatic MR imaging? J Magn Reson Imaging (2010) 0.91
Five year time course of celiac disease serology during gluten free diet: results of a community based "CD-Watch" program. Dig Liver Dis (2010) 0.90
Localized mucinous bronchioloalveolar carcinoma of the lung: thin-section computed tomography and fluorodeoxyglucose positron emission tomography findings. Jpn J Radiol (2010) 0.90
Intravoxel incoherent motion imaging of focal hepatic lesions. J Magn Reson Imaging (2012) 0.90
Intravoxel incoherent motion imaging of the kidney: alterations in diffusion and perfusion in patients with renal dysfunction. Magn Reson Imaging (2012) 0.90
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study. Eur J Heart Fail (2005) 0.89
Hepatitis activity should be considered a confounder of liver stiffness measured with MR elastography. J Magn Reson Imaging (2014) 0.89
Metal and motion artifacts by cone beam computed tomography (CBCT) in dental and maxillofacial study. Radiol Med (2015) 0.88
Diffusion-weighted imaging in optic neuritis. Can Assoc Radiol J (2012) 0.88
Mental disorders associated with benzodiazepine use among older primary care attenders--a regional survey. Soc Psychiatry Psychiatr Epidemiol (2005) 0.87
Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection? J Magn Reson Imaging (2011) 0.87
[A case of gastric xanthogranuloma associated with early gastric cancer]. Nihon Shokakibyo Gakkai Zasshi (2009) 0.87
Epidemiological, clinical and histopathologic characteristics of celiac disease: results of a case-finding population-based program in an Italian community. Scand J Gastroenterol (2005) 0.87
Isolated fallopian tube torsion in an adolescent: CT features. Pediatr Radiol (2002) 0.86
Persistent contrast enhancement by sterically stabilized paramagnetic liposomes in murine melanoma. Magn Reson Med (2004) 0.86
Magnetic resonance imaging for diagnosing chronic pancreatitis. J Gastroenterol (2007) 0.85
Biodegradability, toxicity and mutagenicity of detergents: Integrated experimental evaluations. Ecotoxicol Environ Saf (2012) 0.85
Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma. J Magn Reson Imaging (2013) 0.84
Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject With Solid Cancer in an Italian Multicenter Study. J Acquir Immune Defic Syndr (2015) 0.84
Intrabiliary metastasis from rectal cancer mimicking peripheral papillary-type cholangiocarcinoma. J Hepatol (2004) 0.84
Hepatocellular carcinoma risk assessment using gadoxetic acid-enhanced hepatocyte phase magnetic resonance imaging. Hepatol Res (2014) 0.84
Alcohol dehydrogenase 3, glutathione S-transferase M1 and T1 polymorphisms, alcohol consumption and hepatocellular carcinoma (Italy). Cancer Causes Control (2005) 0.83
Occult hepatitis B virus and the risk for chronic liver disease: a meta-analysis. Dig Liver Dis (2012) 0.83
Association of splenic MR elastographic findings with gastroesophageal varices in patients with chronic liver disease. J Magn Reson Imaging (2013) 0.83
Assessment of reference values for polychlorinated biphenyl concentration in human blood. Chemosphere (2005) 0.83
Polychlorinated biphenyls and cancer: an epidemiological assessment. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev (2013) 0.83
Thyroid papillary carcinoma with micropapillary and hobnail growth pattern: a histological variant with intermediate malignancy? Thyroid (2009) 0.83
Review of epidemiological studies on drinking water hardness and cardiovascular diseases. Eur J Cardiovasc Prev Rehabil (2006) 0.82
Resovist enhanced MR imaging of the liver: does quantitative assessment help in focal lesion classification and characterization? J Magn Reson Imaging (2009) 0.82
Associations among q-space MRI, diffusion-weighted MRI and histopathological parameters in meningiomas. Eur Radiol (2013) 0.82
Prenatal presentation and postnatal evolution of a patient with Jansen metaphyseal dysplasia with a novel missense mutation in PTH1R. Am J Med Genet A (2013) 0.82
Magnetic resonance diffusion-weighted imaging: quantitative evaluation of age-related changes in healthy liver parenchyma. Magn Reson Imaging (2011) 0.82
Thin-section CT of the mediastinum in preoperative N-staging of non-small cell lung cancer: comparison with FDG PET. Eur J Radiol (2009) 0.82
Biliopancreatic reflux via anomalous pancreaticobiliary junction. Surgery (2004) 0.81
High b-value q-space analyzed diffusion-weighted MRI using 1.5 tesla clinical scanner; determination of displacement parameters in the brains of normal versus multiple sclerosis and low-grade glioma subjects. J Neuroimaging (2011) 0.81
The epidemiological pattern of chronic liver diseases in a community undergoing voluntary screening for hepatitis B and C. Dig Liver Dis (2011) 0.81
MRI of hepatic epithelioid hemangioendothelioma (HEH). J Magn Reson Imaging (2013) 0.81
T2-weighted and diffusion-weighted MRI for discriminating benign from malignant focal liver lesions: diagnostic abilities of single versus combined interpretations. J Magn Reson Imaging (2012) 0.81
Early hepatocellular carcinomas showing isointensity or hyperintensity in gadoxetic acid-enhanced, hepatocyte-phase magnetic resonance images. J Comput Assist Tomogr (2013) 0.80
Bile leak after elective laparoscopic cholecystectomy: role of MR imaging. J Radiol Case Rep (2013) 0.80
Cross-sectional comparison of the characteristics of respiratory allergy in immigrants and Italian children. Pediatr Allergy Immunol (2014) 0.80
Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival. Am J Gastroenterol (2003) 0.80
[Health Search--Research Institute of the Italian Society of General Practice: the creation of a research database in general practice]. Epidemiol Prev (2004) 0.80
Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy. AIDS Patient Care STDS (2013) 0.80
MR-based measurements of portal vein flow and liver stiffness for predicting gastroesophageal varices. Magn Reson Med Sci (2013) 0.80
The nature of cartilage stippling in chondrodysplasia punctata: histopathological study of Conradi-Hünermann syndrome. Fetal Pediatr Pathol (2008) 0.79
A review of the actual knowledge of the processes governing growth and development of long bones. Fetal Pediatr Pathol (2011) 0.79
Diffusion- and T₂-weighted MR imaging of the liver: effect of intravenous administration of gadoxetic acid disodium. Magn Reson Med Sci (2012) 0.79
Bayesian prediction for liver fibrosis staging: combined use of elastography and serum fibrosis markers. Hepatology (2013) 0.79
Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study. Eur Heart J (2004) 0.79
High prevalence of atopy, but not of asthma, among children in an industrialized area in North Italy: the role of familial and environmental factors--a population-based study. Pediatr Allergy Immunol (2007) 0.79
Computed tomography (CT) venography with dual-energy CT: low tube voltage and dose reduction of contrast medium for detection of deep vein thrombosis. J Comput Assist Tomogr (2014) 0.79
Diffusion-weighted magnetic resonance imaging in the prediction and assessment of chemotherapy outcome in liver metastases. Radiol Med (2014) 0.79